|
Resolution: standard / high Figure 2.
Changes in CD20+ B cells. Median percentage change from baseline in CD20+ B cells in (a) single-dose cohorts and (b) double-dose cohorts. Arrows indicate time of belimumab administration.
Furie et al. Arthritis Research & Therapy 2008 10:R109 doi:10.1186/ar2506 |
